Arch Therapeutics' (ARTH) AC5 Topical Hemostatic Devic Met Primary Endpoints in Clinical Study
Go back to Arch Therapeutics' (ARTH) AC5 Topical Hemostatic Devic Met Primary Endpoints in Clinical Study| Arch Therapeutics, Inc. (AMEX: ARTH) | Delayed: 1.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.18 | 52 Week High | $0.95 | |||
| Open | $1.18 | 52 Week Low | $0.16 | |||
| Day High | $1.18 | P/E | N/A | |||
| Day Low | $1.18 | EPS | $-0.03 | |||
| Volume | 125 | |||||
